Related Experiment Video
Updated: Dec 3, 2025

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
Published on: April 28, 2023
Modulation of Pancreatic Neuroendocrine Neoplastic Cell Fate by Autophagy-Mediated Death
Sami Matrood1, Nicola de Prisco2,3, Thaddeus T Wissniowski4
1Department of Visceral Thoracic and Vascular Surgery, Philipps University Marburg, Marburg, Germany.
Introduction:
Autophagic cell death in cancer cells can be mediated by inhibition of deacetylases. Although extensive studies have focused on the autophagic process in cancer, little is known about the role of autophagy in degrading cytosolic and nuclear components of pancreatic neuroendocrine neoplastic (pNEN) cells leading to cell death, thus improving the therapy of patients affected by pNEN.
Methods:
2D and 3D human pNEN and pancreatic stellate cells were treated with panobinostat and bafilomycin. Autophagy markers were detected by RT-qPCR, immunofluorescence, and Western blot. Autophagosomes were detected by electron microscopy and their maturation by real-time fluorescence of LC3B stable transfected cells. ChIP was performed at the cAMP responsive element. Immunofluorescence was performed in murine pancreatic tissue.
Results:
We observed that pan-deacetylase inhibitor panobinostat treatment causes autophagic cell death in pNEN cells. We also found that although AMPK-α phosphorylation is counterbalanced by phosphorylated AKT, it is not capable to inhibiting autophagic cell death. However, the binding activity of the cAMP responsive element is prompted by panobinostat. Although autophagy inhibition prevented autophagosome synthesis, maturation, and cell death, panobinostat treatment induced the accumulation of mature autophagosomes in the cytosol and the nucleus, leading to disruption of the organelles, cellular digestion, and decay. Observation of autophagosome membrane proteins Beclin1 and LC3B aggregation in murine pancreatic islets indicates that autophagy restoration may also lead to autophagosome aggregation in murine insulinoma cells. A basal low expression of autophagy markers was detectable in patients affected by pNEN, and, interestingly, the expression of these markers was significantly lower in metastatic pNEN.
Discussion/Conclusion:
Our study highlights that the autophagy functional restoration and prolongation of this catabolic process, mediated by inhibition of deacetylase, is responsible for the reduction of pNEN cells. Prompting of autophagy cell death could be a promising strategy for the therapy of pNEN.
Insights
Pancreatic neuroendocrine neoplastic cells undergo autophagic cell death when deacetylase inhibitors are used. Restoring autophagy may offer a new therapeutic strategy for pNEN patients.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Autophagic cell death is a known mechanism in cancer therapy.
- The role of autophagy in pancreatic neuroendocrine neoplasms (pNEN) is not well understood.
- Investigating autophagy in pNEN could reveal new therapeutic targets.
Purpose of the Study:
- To investigate the role of autophagy in pNEN cell death.
- To determine if inhibiting deacetylases can induce autophagic cell death in pNEN.
- To explore the therapeutic potential of modulating autophagy in pNEN.
Main Methods:
- Human pNEN cells were treated with panobinostat (a deacetylase inhibitor) and bafilomycin.
- Autophagy markers (Beclin1, LC3B) and cell death were assessed using molecular and imaging techniques.
- Autophagosome formation, maturation, and cellular localization were analyzed via electron microscopy and live-cell imaging.
Main Results:
- Panobinostat induced autophagic cell death in pNEN cells, characterized by autophagosome accumulation in the cytosol and nucleus.
- Autophagy inhibition prevented cell death, while panobinostat treatment led to cellular digestion and decay.
- Reduced autophagy marker expression was observed in human pNEN patients, particularly in metastatic cases.
Conclusions:
- Deacetylase inhibition triggers autophagic cell death in pNEN cells by restoring and prolonging the autophagic process.
- Targeting autophagy, specifically inducing autophagic cell death, presents a promising therapeutic strategy for pNEN.
- Autophagy modulation could be key to improving treatment outcomes for pNEN patients.
More Related Videos
08:40Visualization of Endogenous Mitophagy Complexes In Situ in Human Pancreatic Beta Cells Utilizing Proximity Ligation Assay
Published on: May 2, 2019
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...